NCT lookup
Pull any trial record directly from ClinicalTrials.gov.
Role of Immune System in Obesity-related Inflammation and Cardiometabolic Risk
Role of Immune System in Obesity-related Inflammation and Cardiometabolic Risk
Active Not RecruitingNA
Sponsor: Washington University School of Medicine
Conditions: Non-alcoholic Fatty Liver Disease, Metabolic Syndrome, Metabolically Abnormal Obesity, Metabolically Normal Obesity, Obesity
Interventions: Weight loss
Countries: United States
The purpose of this study is to learn more about how the body stores fat in and around organs (for example in the liver) and why this affects some people's health more than others. Understanding this may lead to better treatments for diseases such as diabetes and cardiovascular disease.
Eligibility overview
Sex: ALL
Age: 18 Years to 90 Years
Healthy volunteers: Yes
Study type: INTERVENTIONAL
Eligibility criteria
Inclusion Criteria: Lean, metabolically healthy group - Body mass index (BMI) 18.5-24.9 kg/m2, HbA1C ≤5.6%, fasting plasma glucose concentration \<100 mg/dl, 2-h OGTT plasma glucose concentration \<140 mg/dl and intrahepatic triglyceride (IHTG) content ≤5%. Obese, metabolically healthy group - BMI ≥30 kg/m2, HHbA1C ≤5.6%, fasting plasma glucose concentration \<100 mg/dl, 2-h OGTT plasma glucose concentration \<140 mg/dl and intrahepatic triglyceride (IHTG) content ≤5%. Obese, metabolically healthy group - BMI ≥30 kg/m2, IHTG content ≥5.6% and HbA1C ≥5.7% or fasting plasma glucose concentration ≥100 mg/dl or 2-h OGTT plasma glucose concentration ≥140 mg/dl. Lean, scheduled for inguinal hernia, hysterectomy or myomectomy surgery - BMI 18.5-24.9 kg/m2, HbA1C ≤5.6%, fasting plasma glucose concentration \<100 mg/dl, 2-h OGTT plasma glucose concentration \<140 mg/dl and IHTG content ≤5%. Obese, scheduled for bariatric and gallbladder surgery - BMI ≥35.0kg/m2 Exclusion Criteria: * active or previous history of liver diseases other than NAFLD * history of alcohol abuse * currently consuming ≥20 g alcohol/day * severe hypertriglyceridemia (\>300 mg/dL) * smoke tobacco * cancer diagnosis within the previous 5 years * medications that might confound the study results * pregnancy or lactation * exercise \>2 h/week
Locations (1)
- St Louis, Missouri, United States